Ruey-ching (Richard) Hwang, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ruey-ching (Richard) Hwang, PhD


Ruey-ching (Richard) Hwang, PhD
Senior Director,
Pharmaceutical Sciences
Pfizer Global R&D

Richard (Ruey-ching) Hwang is senior director of clinical supply manufacturing at Pfizer and has been with the company since 2003. He previously held positions at Pharmacia, Mallinckrodt, and G.D. Searle.

Hwang has authored and/or coauthored nearly 20 papers, given nearly 40 presentations and training courses, and presented more than 20 posters at poster sessions. He is a member of the American Association of Pharmaceutical Scientists (AAPS) and is a member of Pharmaceutical Technology’s Editorial Advisory Board.

He holds an MBA from the Keller Graduate School of Management at DeVry University and a PhD in Pharmaceutics from the College of Pharmacy at the University of Iowa. He received his BS in Pharmacy from the School of Pharmacy, College of Medicine, National Taiwan University.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here